Alpha Paradigm Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-168
Closed -$12K 499
2022
Q3
$12K Buy
+168
New +$13.2K 0.01% 441
2022
Q1
Sell
-2,640
Closed -$225K 560
2021
Q4
$225K Buy
2,640
+1,691
+178% +$132K 0.09% 324
2021
Q3
$72K Sell
949
-1,162
-55% -$92.3K 0.03% 448
2021
Q2
$172K Sell
2,111
-255
-11% -$20.9K 0.06% 376
2021
Q1
$187K Sell
2,366
-3,009
-56% -$236K 0.07% 312
2020
Q4
$460K Buy
+5,375
New +$444K 0.16% 163

Other funds holding CL

Alpha Paradigm Partners's CL Position: Q4 2022 in Review

Alpha Paradigm Partners sold out of Colgate-Palmolive (CL) in Q4 2022, closing a stake of 168 shares — an estimated $12K sold.

Alpha Paradigm Partners first reported a position in CL in Q4 2020 and held it in 6 quarters. The position peaked at $460K in Q4 2020. 1,698 funds tracked by Wall St. Rank hold CL as of Q4 2022.

  • Alpha Paradigm Partners reported no remaining Colgate-Palmolive position as of Q4 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 168 Colgate-Palmolive shares in Q4 2022, an estimated $12K.
  • Alpha Paradigm Partners first reported a position in Colgate-Palmolive in Q4 2020 and held it in 6 quarters.
  • Alpha Paradigm Partners's Colgate-Palmolive position peaked at $460K in Q4 2020.
  • 1,698 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.